Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2014 August;66(4) > Minerva Ginecologica 2014 August;66(4):377-81

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

ORIGINAL ARTICLES  


Minerva Ginecologica 2014 August;66(4):377-81

language: English

An alternative approach for the treatment of vaginal atrophy

Quaranta L., Ottolina J., Parma M., Chionna R., Sileo F., Dindelli M., Origoni M., Candiani M., Salvatore S.

Gynecology Department, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, School of Medicine, Milan, Italy


PDF  


AIM: The aim of this study was to determine the efficacy of a new topic non-hormonal treatment for postmenopausal women complaining of symptoms of vaginal atrophy.
METHODS: Patients included in the study were prescribed Sinecol gel (AM PHARMA Srl, Vimercate, Monza and Brianza, Italy) application once a day for 20 consecutive days. Sinecol gel is a topic compound for vaginal atrophy containing hyaluronic acid, that is known to improve vaginal elasticity, lactoperoxidase, Xantham gum and glucose oxidase, which have protective and antibacterial action. We evaluated each patient before and after treatment, both subjectively with the “Visual Analogical Scale” (VAS) and objectively with the “Vaginal Health Index” (VHI).
RESULTS: We observed a significant clinical improvement of the subjective and objective assessment of symptoms severity with a p value <0.001 at the end of the treatment compared to baseline.
CONCLUSION: Sinecol gel appears to be an effective and valid non-hormonal alternative to the estrogen therapy for vaginal atrophy.

top of page

Publication History

Cite this article as

Corresponding author e-mail

salvatore.stefano@hsr.it